← Data apps
Johnson & Johnson (JNJ) Financial Statistics
Pharmaceuticals
Johnson & Johnson (JNJ) reported revenue of $96.4B and net income of $21B (TTM to Mar 2026, SEC filings). Its market cap was $633.2B as of 2026-07-02. By revenue it ranks #1 of 4 pharmaceuticals companies covered on autario.
Key metrics at a glance
Net Income
TTM to Mar 2026
Market Cap
as of 2026-07-02
P/E Ratio
as of 2026-07-02
Income Statement
Revenue, operating income, and profitability from SEC filings, trailing-12-month.
Per Share
Per-share earnings and the share count, split-adjusted to today's basis.
Valuation & Market
Share price and market-based valuation, derived from adjusted prices and TTM earnings.
Pharmaceuticals peers
Covered same-sector companies on autario, compared on the latest verified figures.
Revenue (TTM) #1 of 4 pharmaceuticals companies covered
Sector median: $50.3B
Net Income (TTM) #1 of 4 pharmaceuticals companies covered
Sector median: $8.5B
Market Cap #1 of 4 pharmaceuticals companies covered
Sector median: $182.5B
Use this data programmatically
# Johnson & Johnson datasets (JSON, no signup)
curl "https://autario.com/api/v1/public/markets/JNJ/datasets"
# Company snapshot (MCP, for LLMs like Claude or ChatGPT)
get_company_snapshot("JNJ")
Financial data from SEC EDGAR filings and split-adjusted market prices, aggregated and verified on autario.com. Each value links to its source dataset.
Open this profile on autario.com.